Linagliptin, Dapagliflozin & Metformin Hydrochloride Tablets

Description

Composition: Each tablet contains:

• Linagliptin 5 mg

• Dapagliflozin 10 mg

• Metformin Hydrochloride 1000 mg

Dosage Form: Tablet
Route of Administration: Oral

Drug Class:

• Linagliptin – DPP-4 (Dipeptidyl Peptidase-4) Inhibitor

• Dapagliflozin – SGLT2 (Sodium-Glucose Co-Transporter-2) Inhibitor

• Metformin Hydrochloride – Biguanide Antidiabetic Agent

Therapeutic Use: Indicated for the management of type 2 diabetes mellitus to improve blood sugar control as part of a comprehensive treatment plan including diet and exercise.